SAN DIEGO (AP) — SAN DIEGO (AP) — Neurocrine Biosciences Inc. (NBIX) on Wednesday reported fourth-quarter earnings of $153.7 million.
The San Diego-based company said it had net income of $1.48 per share. Earnings, adjusted for one-time gains and costs, were $1.88 per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $2.25 per share.
The biopharmaceutical company posted revenue of $805.5 million in the period, which beat Street forecasts. Eleven analysts surveyed by Zacks expected $782.9 million.
For the year, the company reported profit of $478.6 million, or $4.67 per share. Revenue was reported as $2.86 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX
/Cisco%20Systems%2C%20Inc_%20HQ-by%20Sundry%20Photography%20via%20iStock.jpg)
